Clinuvel Pharmaceuticals (UR9.F) Q3 2023 Earnings

Aug 29Confirmed
Q1 2022
Q3 2022
Q1 2023
Q3 2023
0.07
0.12
0.17
0.22

Details

Expected EPS
0.22040554630882914
Actual EPS
0.22040554630882914
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦UR9.F⁩) has reported earnings of ⁦0.22040554630882914⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts